The study is based in Pakistan with our Collaborators (Aga Khan University, Dow University, the Liver Clinic, Gujranwala and Dr Huma Qureshi's Clinic, Karachi) in Pakistan and colleagues at Oxford University and Bristol University. It comprises a screening study and a second-line treatment study.